Adaptimmune Therapeutics PLC - ADAPY
Sector:
Healthcare
· Industry:
Biological Products, (No Diagnostic Substances)
Website:
No information yet
· Social:
No information yet
Company profile
Powered by TradingView
Quarter snapshot
Latest / Compare
Q4 2025
· Q3 2025
Value (USD)
Total reported value ($000)
$77K
QoQ value delta ($000)
-$5.404M
(-98.6%)
Implied price effect (QoQ)
-64.17%
Shares
Total shares
1,660,904
QoQ shares delta
-40,704,342
(-96.08%)
Total shares held by funds (by quarter)
Market chart (ADAPY)
Powered by TradingView
Interactive chart by
TradingView.
Top holders (Q4 2025)
Top 25 only
Full list
| Manager | Value ($000) | Shares | % of 13F |
|---|---|---|---|
| JOSH ARNOLD INVESTMENT CONSULTANT, LLC | 37 | 20,000 | 0.03% |
| Empirical Finance, LLC | 20 | 800,000 | 0.0% |
| Rathbones Group PLC | 11 | 432,818 | 0.0% |
| XTX Topco Ltd | 9 | 353,836 | 0.0% |
| BARCLAYS PLC | 0 | 2,532 | 0.0% |
| ACADIAN ASSET MANAGEMENT LLC | 0 | 17,167 | 0.0% |
| RHUMBLINE ADVISERS | 0 | 3,661 | 0.0% |
| SIMPLEX TRADING, LLC | 0 | 18,610 | 0.0% |
| X-Square Capital, LLC | 0 | 11,359 | 0.0% |
| TD Waterhouse Canada Inc. | 0 | 14 | 0.0% |
| Raiffeisen Bank International AG | 0 | 907 | 0.0% |